Showing results (1-10 of 763) with videos related to
Sort By:
Pageof 77
Advanced Drug Delivery Reviews|September 28, 2011
RNA therapeutics targeting osteoclast-mediated excessive bone resorptionYuwei Wang, David W GraingerAdvanced Drug Delivery Reviews|March 23, 2019
Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environmentsYuwei Wang, David W GraingerPharmaceutical Research|March 25, 2010
siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorptionYuwei Wang, David W GraingerTherapeutic Delivery|October 15, 2013
Developing siRNA therapies to address osteoporosisYuwei Wang, David W GraingerMolecular Pharmaceutics|December 29, 2010
Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast culturesYuwei Wang, Alexandra Panasiuk, David W GraingerJournal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2010
Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulationHironobu Takahashi, Yuwei Wang, David W GraingerBiomaterials|September 7, 2012
Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterialsYuwei Wang, Kenny K Tran, Hong Shen, et al.Expert Opinion on Biological Therapy|July 23, 2004
Controlled-release and local delivery of therapeutic antibodiesDavid W GraingerBiomaterials|July 24, 2007
Peer review as professional responsibility: a quality control system only as good as the participantsDavid W GraingerInternational Journal of Pharmaceutics|April 30, 2013
Connecting drug delivery reality to smart materials designDavid W GraingerPageof 77